FDA Clears Karl Storz Rubina Lens Exoscope for Open Surgery

The 2026 Marketplace Cliff: Analyzing the Fallout of Expired ACA Subsidies

The expiration of enhanced ACA subsidies is driving coverage losses, higher premiums, and underinsurance, increasing uncompensated care while straining patients, providers, and healthcare systems nationwide.

Beyond Metabolic Health: The Emerging Frontier of Incretin Therapies in Addiction

Emerging evidence suggests GLP-1 receptor agonists may reduce alcohol cravings and heavy drinking, offering a promising new treatment approach for alcohol use disorder, especially with obesity.

Endovascular Band Placement May Avoid Or Delay Infant CHD Surgery

Endovascular pulmonary artery banding offers a less invasive alternative for selected infants with congenital heart disease, stabilizing pulmonary blood flow while delaying higher-risk open-heart surgery.

Stroke Care and Outcomes Among Patients Experiencing Homelessness: Translating Evidence into Clinical Practice

A large meta-analysis found people experiencing homelessness receive fewer time-critical stroke treatments, highlighting urgent needs for equitable triage, standardized care pathways, and stronger post-discharge support.

FDA Clears Karl Storz Rubina Lens Exoscope for Open Surgery

FDA clearance of a 4K fluorescence-guided exoscope enhances open surgery by improving visualization, teamwork, and real-time tissue perfusion assessment to support safer surgical decisions.